Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr
Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021
Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in-their respective categories as on March 2021.
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
The company posted net profit of Rs.7.61 crores for the period ended December 31, 2019.
The company posted net profit of Rs.62.17 crores for the period ended December 31, 2019.
The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.
The company's business in India geography posted strong growth during the quarter as it grew by 20% on a y-o-y basis and registered revenues of Rs. 1,643 crore.
The company posted net loss of Rs. 661.16 crores for the period ended December 31, 2019.
During the quarter, Zydus Wellness completed the acquisition of Comfort Click Limited and its subsidiaries
Subscribe To Our Newsletter & Stay Updated